111 related articles for article (PubMed ID: 21255063)
1. Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinoma.
Searchfield L; Price SA; Betton G; Jasani B; Riccardi D; Griffiths DF
Histopathology; 2011 Jan; 58(2):180-90. PubMed ID: 21255063
[TBL] [Abstract][Full Text] [Related]
2. CD151 expression can predict cancer progression in clear cell renal cell carcinoma.
Yoo SH; Lee K; Chae JY; Moon KC
Histopathology; 2011 Jan; 58(2):191-7. PubMed ID: 21323946
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiation.
Grignon DJ; Abdel-Malak M; Mertens WC; Sakr WA; Shepherd RR
Mod Pathol; 1994 Feb; 7(2):186-9. PubMed ID: 8008741
[TBL] [Abstract][Full Text] [Related]
4. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
[TBL] [Abstract][Full Text] [Related]
5. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
[TBL] [Abstract][Full Text] [Related]
6. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
[TBL] [Abstract][Full Text] [Related]
9. Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Jung K
Cancer Sci; 2008 Jun; 99(6):1188-94. PubMed ID: 18422740
[TBL] [Abstract][Full Text] [Related]
10. Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinoma.
Richter EN; Oevermann K; Buentig N; Storkel S; Dallmann I; Atzpodien J
J Urol; 2002 Aug; 168(2):460-4. PubMed ID: 12131288
[TBL] [Abstract][Full Text] [Related]
11. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma.
Chuang ST; Chu P; Sugimura J; Tretiakova MS; Papavero V; Wang K; Tan MH; Lin F; Teh BT; Yang XJ
Am J Clin Pathol; 2005 Mar; 123(3):421-9. PubMed ID: 15716239
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of COX-2 expression in renal cell carcinoma.
Kankuri-Tammilehto MK; Söderström KO; Pelliniemi TT; Vahlberg T; Pyrhönen SO; Salminen EK
Anticancer Res; 2010 Jul; 30(7):3023-30. PubMed ID: 20683050
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas.
Macher-Goeppinger S; Bermejo JL; Wagener N; Hohenfellner M; Haferkamp A; Schirmacher P; Roth W
Cancer Lett; 2011 Feb; 301(2):203-11. PubMed ID: 21196076
[TBL] [Abstract][Full Text] [Related]
17. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
18. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
Sun M; Shariat SF; Cheng C; Ficarra V; Murai M; Oudard S; Pantuck AJ; Zigeuner R; Karakiewicz PI
Eur Urol; 2011 Oct; 60(4):644-61. PubMed ID: 21741163
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma.
Cho HJ; Kim SJ; Ha US; Hong SH; Kim JC; Choi YJ; Hwang TK
Eur Urol; 2009 Dec; 56(6):1006-12. PubMed ID: 19135776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
